The Biden administration is directing insurance companies to offer PrEP without copays or deductibles. PrEP, or pre-exposure prophylaxis, refers to two antiviral medications — under the brand names of Truvada, which was approved by the federal Food and Drug Administration in 2012, and Descovy, which was approved in 2019 — that are taken by HIV-negative people to prevent HIV infection.
According to guidance released July 19 jointly by the U.S. Departments of Labor, Health and Human Services, and the Treasury, the Patient Protection and Affordable Care Act requires insurance companies to provide evidence-based services with an "A" or "B" rating from the U.S.